A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial (Q33308737)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial
scientific article

    Statements

    A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial (English)
    Shinji L Okitsu
    Nicole Westerfeld
    Marija Curcic
    Andreas R Kammer
    Markus S Mueller
    John A Robinson
    Rinaldo Zurbriggen
    5 December 2007

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit